International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Jun 19, 2020, after the close
10-Q filed Jun 19, 2020, 80 days after period end · 0001564590-20-029953
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $2.36M | $2.22M | $2.63M | $2.01M |
| Net Income | -$373.00K | -$906.00K | -$830.00K | -$3.08M |
| EPS Diluted | -$0.05 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.12 |
| -$0.14 |
| -$0.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
